59MO Final analysis of AK105-302: A randomized, double-blind, placebo-controlled, phase III trial of penpulimab plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC
Authors:
- B. HanBHB. Han
- S. JiaoSJS. Jiao
- J. ChenJCJ. Chen
- Z. WangZWZ. Wang
- Y. ZhaoYZY. Zhao
- G. ZhangGZG. Zhang
- G. ChenGCG. Chen
- M. ZhouMZM. Zhou
- J. ZhouJZJ. Zhou
- Y. DuYDY. Du
- L. WuLWL. Wu
- Z. XuZXZ. Xu
Open Access
- 9 December 2022
- journal article
- Published by Elsevier in Immuno-Oncology and Technology
- Vol. 16